Meta-analysis of the diagnostic value of ¹⁸F-FDG PET/CT in the recurrence of epithelial ovarian cancer.

ABSTRACT:

Background

Ovarian cancer is the leading cause of cancer-related death among gynecologic malignancies. With much evidence suggesting that ¹⁸F-FDG PET/CT may be an excellent imaging test for the diagnosis of epithelial ovarian cancer recurrence, we conducted a systematic review and meta-analysis to summarize relevant studies and evaluate the accuracy and application value of ¹⁸F-FDG PET/CT in the diagnosis of recurrence of epithelial ovarian cancer.

Materials and methods

Clinical trials of ¹⁸F-FDG PET/CT for the diagnosis of recurrence of epithelial ovarian cancer were systematically searched in PubMed, Embase, Cochrane Library, Web of Science and OVID database. The relevant literature was searched until May 22, 2022. Quality Assessment of Dia

SUBMITTER: Wang X 

PROVIDER: S-EPMC9676502 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature